Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) posted Non-Current Assets of $623.1 million for Q1 2026, down 3.82% on a QoQ basis from $647.9 million in Q4 2025, and down 14.52% year-over-year from $728.9 million in Q1 2025.

Ginkgo Bioworks Holdings (DNA) Non-Current Assets (2020 - 2026) Analysis & Trends

Ginkgo Bioworks Holdings' Non-Current Assets history runs 7 years deep, the most recent figure standing at $623.1 million for Q1 2026.

  • Quarterly Non-Current Assets fell 14.52% year-over-year to $623.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 billion (down 15.86% YoY) and the FY2025 annual result came in at $647.9 million, down 16.37% from the prior year.
  • Non-Current Assets was $623.1 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $647.9 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2023 and bottomed at $351.9 million in Q1 2022.
  • A 5-year average of $732.7 million and a median of $708.0 million in 2025 frame the typical range for Non-Current Assets.
  • Peak annual rise in Non-Current Assets reached 213.05% in 2022, while the deepest fall reached 79.6% in 2022.
  • Ginkgo Bioworks Holdings' Non-Current Assets stood at $1.1 billion in 2022, then slumped by 39.08% to $663.6 million in 2023, then rose by 16.74% to $774.7 million in 2024, then declined by 16.37% to $647.9 million in 2025, then declined by 3.82% to $623.1 million in 2026.
  • Business Quant data shows DNA's Non-Current Assets at $623.1 million in Q1 2026, $647.9 million in Q4 2025, and $683.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Ginkgo Bioworks Holdings 517.16 Mn 373.30 Mn 16.38 Mn 623.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 623.12 Mn
Dec 31, 2025 647.86 Mn
Sep 30, 2025 683.08 Mn
Jun 30, 2025 707.98 Mn
Mar 31, 2025 728.93 Mn
Dec 31, 2024 774.71 Mn
Sep 30, 2024 818.40 Mn
Jun 30, 2024 841.89 Mn
Mar 31, 2024 678.74 Mn
Dec 31, 2023 663.59 Mn
Sep 30, 2023 884.55 Mn
Jun 30, 2023 1.07 Bn
Mar 31, 2023 1.09 Bn
Dec 31, 2022 1.09 Bn
Sep 30, 2022 408.69 Mn
Jun 30, 2022 395.37 Mn
Mar 31, 2022 351.89 Mn
Dec 31, 2021 347.95 Mn
Sep 30, 2021 340.02 Mn
Jun 30, 2021 1.73 Bn